{"id":22423,"date":"2019-01-22T10:46:56","date_gmt":"2019-01-22T10:46:56","guid":{"rendered":"https:\/\/corporate.webfactory.ferring.tech\/?p=22423"},"modified":"2021-05-10T17:47:34","modified_gmt":"2021-05-10T16:47:34","slug":"ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments","status":"publish","type":"post","link":"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/","title":{"rendered":"Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments"},"content":{"rendered":"[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h2 style=\"color: #0088ce\">Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments<\/h2>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<ul>\n<li>Collaboration brings together expertise from Ferring, Rebiotix and Karolinska Institutet to unlock the potential of the human microbiome<\/li>\n<\/ul>\n<ul>\n<li>The collaboration will investigate the role of the microbiome in reproductive medicine and women\u2019s health and gastroenterology through 10 clinical studies involving approximately 9,000 people<\/li>\n<\/ul>\n<ul>\n<li>The data collected will support future research and development in areas of high unmet need, including recurrent pregnancy loss, preterm birth and inflammatory bowel disease<\/li>\n<\/ul>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h3 class=\"p1\" style=\"color: #0088ce\">Saint-Prex, Switzerland \u2013 22 January, 2019 \u2013<\/h3>\n<p class=\"p1\">Ferring Pharmaceuticals and Karolinska Institutet announced today a five-year extension of their collaboration to explore the potential of the human microbiome in reproductive medicine and women\u2019s health and gastroenterology. The collaboration brings together specialist expertise from Karolinska Institutet in early stage research, Rebiotix Inc. (acquired by Ferring in 2018), a late-stage clinical microbiome company, and Ferring\u2019s therapeutic area and commercialisation capabilities.<\/p>\n<p>The extension includes six reproductive health clinical studies of approximately 6,000 women and babies and four gastroenterology studies of approximately 3,000 adults and children, to further investigate the role of the microbiome in areas of high unmet need including recurrent pregnancy loss, preterm birth and inflammatory bowel disease.<\/p>\n<p><em>\u201cThe extension of this partnership presents an exciting research opportunity, bringing together unique capabilities of Ferring, Karolinska Institutet and Rebiotix across the clinical development continuum in the mircrobiome space,\u201d<\/em>\u00a0said Lee Jones, Founder, President and Chief Executive Officer, Rebiotix, Inc.<em>\u00a0\u201cThis, together with Ferring\u2019s significant experience in reproductive medicine and gastroenterology, offers the potential to drive future research and development for the next generation of microbiome treatments needed to help more people build healthy families and live better lives.\u201d<\/em><\/p>\n<p>Up to 5% of couples face the heartache of recurrent pregnancy loss<span class=\"s1\"><a href=\"#note1\"><sup>1<\/sup><\/a><\/span> and around 15 million babies are born preterm every year around the world, with approximately 1 million children dying each year due to related complications.<sup><span class=\"s1\"><a href=\"#note2\">2<\/a><\/span><\/sup>\u00a0Over 10 million people worldwide live with the pain and discomfort of inflammatory bowel disease.<sup><span class=\"s1\"><a href=\"#note3\">3<\/a><\/span><\/sup> With reproductive health and inflammatory bowel concerns on the rise,<sup><span class=\"s1\"><a href=\"#note2\">2<\/a><\/span>,<span class=\"s1\"><a href=\"#note4\">4<\/a><\/span><\/sup>\u00a0there is a need to increase understanding of their causes and develop new solutions.<\/p>\n<p><em>\u201cThis innovative public-private partnership demonstrates our ongoing, shared commitment to investigating the human microbiome,\u201d<\/em>\u00a0said Lars Engstrand, Professor at Karolinska Institutet and Director of the Center for Translational Microbiome Research.\u00a0<em>\u201cIt will support the expansion of Karolinska Institutet\u2019s foundation of robust biological data and drive our understanding of the microbiome\u2019s impact on important reproductive and gut health challenges.\u201d<\/em><\/p>\n<p>– ENDS –<\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h3 class=\"p1\" style=\"color: #0088ce\">About Ferring Pharmaceuticals<\/h3>\n<p>Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and women\u2019s health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth. Founded in 1950, privately-owned Ferring now employs approximately 6,500 people worldwide, has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.<\/p>\n<p>Learn more at <a href=\"https:\/\/www.ferring.com\/\">www.ferring.com<\/a>, or connect with us on <a href=\"https:\/\/twitter.com\/ferring\">Twitter<\/a>,\u00a0<a href=\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\">Facebook<\/a>,\u00a0<a href=\"https:\/\/www.instagram.com\/ferringpharmaceuticals\/\">Instagram<\/a>,\u00a0<a href=\"https:\/\/www.linkedin.com\/company\/ferring-pharmaceuticals\/\">LinkedIn<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.youtube.com\/channel\/UC6Ss0Uwv54xTGmM_EDEzQPA\">YouTube<\/a>.<\/p>\n<h3 class=\"p1\" style=\"color: #0088ce\">About Rebiotix Inc.<\/h3>\n<p>Rebiotix Inc., part of the Ferring Pharmaceuticals Group, is a late-stage clinical microbiome company focused on harnessing the power of the human microbiome to revolutionise the treatment of challenging diseases. Rebiotix possesses a deep and diverse clinical pipeline targeting several other disease states with drug products built on its pioneering Microbiota Restoration Therapy\u2122 (MRT\u2122) drug platform. The MRT platform is a standardised, stabilised drug technology that is designed to rehabilitate the human microbiome by delivering a broad consortium of live microbes into a patient\u2019s intestinal tract via a ready-to-use and easy-to-administer format.<\/p>\n<p>For more information on Rebiotix and its pipeline of human microbiome-directed therapies, visit\u00a0<a href=\"https:\/\/www.rebiotix.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">www.rebiotix.com<\/a>.<\/p>\n<h3 class=\"p1\" style=\"color: #0088ce\">About Karolinska Institutet<\/h3>\n<p class=\"p1\">Karolinska Institutet is one of the world\u2019s leading medical universities. Its vision is to significantly contribute to the improvement of human health. Karolinska Institutet accounts for the single largest share of all academic medical research conducted in Sweden and offers the country\u2019s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.<\/p>\n<p>For more information please visit\u00a0<a href=\"https:\/\/ki.se\/en\/startpage\" target=\"_blank\" rel=\"noopener noreferrer\">www.ki.se\/en<\/a>.<\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h3 class=\"p1\" style=\"color: #0088ce\">For more information, please contact<\/h3>\n<p><strong>Lindsey Rodger<\/strong><br \/>\n<em>Senior Manager, Corporate Communications<\/em><br \/>\n+41 58 451 40 23 (direct)<br \/>\n+41 79 191 04 86 (mobile)<br \/>\n<a href=\"mailto:lindsey.rodger@ferring.com\">lindsey.rodger@ferring.com<\/a><\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h3 class=\"p1\" style=\"color: #0088ce\">References<\/h3>\n<ol>\n<li id=\"note1\">Hachem HE, Crepaux V, May-Panloup P, et al. Recurrent pregnancy loss: current perspectives. International Journal of Womens Health. 2017; 9: 331\u2013345.<\/li>\n<li id=\"note2\">WHO. Preterm birth. 2018. Available at:\u00a0<a href=\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/preterm-birth\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/preterm-birth<\/a> [Accessed: January 2019].<\/li>\n<li id=\"note3\">Crohn\u2019s & Colitis Foundation. World IBD Day: Beyond Borders May 19, 2018. Available at:\u00a0<a href=\"http:\/\/www.crohnscolitisfoundation.org\/WorldIBDDay\/\" target=\"_blank\" rel=\"noopener noreferrer\">http:\/\/www.crohnscolitisfoundation.org\/WorldIBDDay\/<\/a> [Accessed: January 2019].<\/li>\n<li id=\"note4\">Kaplan G. The global burden of IBD: from 2015 to 2025. Nature Reviews Gastroenterology & Hepatology. 2015; 12:720\u2013727<\/li>\n<\/ol>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_button button_text=”READ MORE PRESS RELEASES” button_size=”standard” button_colour=”accent” button_type=”standard” rounded=”no” button_dropshadow=”no” button_link=”\/media\/press-releases\/” button_target=”_self” align=”center” animation=”none” animation_delay=”0″ width=”1\/1″ el_position=”first last”]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments [\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Collaboration brings together expertise from Ferring, Rebiotix and Karolinska Institutet to unlock the potential of the human microbiome The collaboration will investigate the role […]<\/p>\n","protected":false},"author":2410,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[242],"tags":[],"class_list":["post-22423","post","type-post","status-publish","format-standard","hentry","category-press-release-2019"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.3 (Yoast SEO v23.3) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments - Ferring Global<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments\" \/>\n<meta property=\"og:description\" content=\"[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments [\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Collaboration brings together expertise from Ferring, Rebiotix and Karolinska Institutet to unlock the potential of the human microbiome The collaboration will investigate the role […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/\" \/>\n<meta property=\"og:site_name\" content=\"Ferring Global\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-22T10:46:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-10T16:47:34+00:00\" \/>\n<meta name=\"author\" content=\"pulse\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ferring\" \/>\n<meta name=\"twitter:site\" content=\"@ferring\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"pulse\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/\"},\"author\":{\"name\":\"pulse\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d\"},\"headline\":\"Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments\",\"datePublished\":\"2019-01-22T10:46:56+00:00\",\"dateModified\":\"2021-05-10T16:47:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/\"},\"wordCount\":1062,\"publisher\":{\"@id\":\"https:\/\/www.ferring.com\/#organization\"},\"articleSection\":[\"PRESS RELEASE 2019\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/\",\"url\":\"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/\",\"name\":\"Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments - Ferring Global\",\"isPartOf\":{\"@id\":\"https:\/\/www.ferring.com\/#website\"},\"datePublished\":\"2019-01-22T10:46:56+00:00\",\"dateModified\":\"2021-05-10T16:47:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ferring.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ferring.com\/#website\",\"url\":\"https:\/\/www.ferring.com\/\",\"name\":\"Ferring Pharmaceuticals\",\"description\":\"Helping people live better lives\",\"publisher\":{\"@id\":\"https:\/\/www.ferring.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ferring.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ferring.com\/#organization\",\"name\":\"Ferring\",\"url\":\"https:\/\/www.ferring.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png\",\"contentUrl\":\"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png\",\"width\":236,\"height\":154,\"caption\":\"Ferring\"},\"image\":{\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\",\"https:\/\/x.com\/ferring\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d\",\"name\":\"pulse\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g\",\"caption\":\"pulse\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments - Ferring Global","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/","og_locale":"en_US","og_type":"article","og_title":"Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments","og_description":"[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments [\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Collaboration brings together expertise from Ferring, Rebiotix and Karolinska Institutet to unlock the potential of the human microbiome The collaboration will investigate the role […]","og_url":"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/","og_site_name":"Ferring Global","article_publisher":"https:\/\/www.facebook.com\/ferringpharmaceuticals\/","article_published_time":"2019-01-22T10:46:56+00:00","article_modified_time":"2021-05-10T16:47:34+00:00","author":"pulse","twitter_card":"summary_large_image","twitter_creator":"@ferring","twitter_site":"@ferring","twitter_misc":{"Written by":"pulse","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/#article","isPartOf":{"@id":"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/"},"author":{"name":"pulse","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d"},"headline":"Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments","datePublished":"2019-01-22T10:46:56+00:00","dateModified":"2021-05-10T16:47:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/"},"wordCount":1062,"publisher":{"@id":"https:\/\/www.ferring.com\/#organization"},"articleSection":["PRESS RELEASE 2019"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/","url":"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/","name":"Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments - Ferring Global","isPartOf":{"@id":"https:\/\/www.ferring.com\/#website"},"datePublished":"2019-01-22T10:46:56+00:00","dateModified":"2021-05-10T16:47:34+00:00","breadcrumb":{"@id":"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ferring.com\/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ferring.com\/"},{"@type":"ListItem","position":2,"name":"Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments"}]},{"@type":"WebSite","@id":"https:\/\/www.ferring.com\/#website","url":"https:\/\/www.ferring.com\/","name":"Ferring Pharmaceuticals","description":"Helping people live better lives","publisher":{"@id":"https:\/\/www.ferring.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ferring.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ferring.com\/#organization","name":"Ferring","url":"https:\/\/www.ferring.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/","url":"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png","contentUrl":"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png","width":236,"height":154,"caption":"Ferring"},"image":{"@id":"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ferringpharmaceuticals\/","https:\/\/x.com\/ferring"]},{"@type":"Person","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d","name":"pulse","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g","caption":"pulse"}}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts\/22423"}],"collection":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/users\/2410"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/comments?post=22423"}],"version-history":[{"count":0,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts\/22423\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/media?parent=22423"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/categories?post=22423"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/tags?post=22423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}